CTRI/2022/12/048265已完成未知
A Proof-of-Concept, Safety and Efficacy Study of Vasu Facial Beauty Oil in Healthy Adult Human Subjects
Vasu Healthcare Private Limited0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Age: 25 to 55 years (both inclusive) at the time of consent.
- •2)Sex: Healthy males and non-pregnant/non-lactating females.
- •3)Females of childbearing potential must have a self-reported negative pregnancy test.
- •4)Subject are generally in good health.
- •5)Subject has a score of at least â??mild skin agingâ?? based on PGA at screening visit.
- •6)Subject with Glogau Skin Age II or III as assessed by the Dermatologist/ Dermatologist Trained Evaluator.
- •7)Subjects with wrinkles at Crowâ??s feet area.
- •8)Subjects with uneven texture skin, uneven skin tone, with dry to normal skin only.
- •9)Subjects with dry skin having <= 40% value as evaluated by MoisturemeterEpiD.
- •10)Subject is willing to forgo cosmetic procedures 3 months prior to and for the duration of the study.
- •11)Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study.
- •12)Subject is able to follow their normal skin care routines and to refrain from introducing any new skin care products during the study.
- •13)Subject is able to forgo changes in baseline medications and nutritional supplements during the study period.
- •14)If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation.
- •15)If currently using hormonal contraception, has been using this form of contraception for at least 6 months and agrees to continue using the same contraception for the duration of the study.
- •16)Subjects are willing not to introduce any new soaps, cleansers, laundry detergents, lotions, creams, shampoos etc. for the duration of the study.
- •17)Subjects are willing to give written informed consent and are willing to follow the study procedure.
- •18)Subjects who have used other marketed products for hair thinning in the past.
- •19)Subjects who commit not to use medicated/ prescription shampoos/hair care products (containing Minoxidil / Anti-thinning agents) or any other hair growth, treatment for thin hair, or hair products other than the test product for the entire duration of the study.
- •20)Willing to use test product throughout the study period.
排除标准
- •1)Subject has a history of allergy or sensitivity to the test treatment ingredients like Kumkumadi tailam, avocado, argan, lavender, rapeseed oil and others etc.
- •2)Subject has used any systemic therapy with chronic antibiotic therapy, retinoids, and/or oral steroids during the 4 weeks prior to the start or anticipates having to use at any point during the study.
- •3)Subject has applied any topical retinoids within 2 weeks of the screening visit or anticipates having to use at any point during the study.
- •4)Subject is not willing to avoid unprotected sun or other UV radiation exposure during the study period.
- •5)Subject is currently pregnant/breastfeeding.
- •6)Subject has a history of alcohol or drug addiction.
- •7)Any other condition which could warrant exclusion from the study, as per the dermatologistâ??s/investigatorâ??s discretion.
- •8)Pregnant or breastfeeding or planning to become pregnant during the study period.
- •9)History of chronic illness which may influence the cutaneous state.
- •10)Subjects participating in other similar cosmetics, devices or therapeutic trials or skin care products within the last four weeks.
研究者
相似试验
已完成
不适用
A Clinical study for safety and practical use of vaccine device using microneedlesJPRN-UMIN000004180Osaka University, Graduate School of Medicine Department of Dermatology20
尚未招募
2 期
Clinical evaluation of VAYU KEELAGA ILAKAM (Internal) with ERUKKATHY THYLAM (External)in the treatment of MUDAKKU VATHAM .CTRI/2018/04/013541Ayothidoss Pandithar Hospital
已完成
不适用
A study to check the skin safety and effect of SkinQGlow Bright Wonder Mask in Healthy Human Subjects withadequate representation of varied skin types (Normal, Oily,Dry, Combined, and Sensitive skin)CTRI/2022/08/044867Health Q Life Sciences Private Limited38
尚未招募
4 期
Comparison of various antihypertensive medicines in patients of high blood pressureCTRI/2018/05/014011Jawaharlal Nehru Medical College
已完成
4 期
A study to compare drugs Vortioxetine and Escitalopram, used for treatment of DepressioCTRI/2019/11/022030Dr Anshul Upadhyay60